SignalFDA/Bio

JOHNSON & JOHNSON (JNJ) TAPS SAIL BIOMEDICINES IN BID FOR CAR-T EDGE OVER BRISTOL MYERS SQUIBB - YAHOO

CAR-T competition intensifies as JNJ targets Bristol Myers Squibb via Sail Biomedicines deal.

What changed

CAR-T competition intensifies as JNJ targets Bristol Myers Squibb via Sail Biomedicines deal.

Why it matters

CAR-T competition intensifies as JNJ targets Bristol Myers Squibb via Sail Biomedicines deal. — impact context not separately stored; see What changed.

Sources

yahoo